CAS: 13734-38-8; Boc-Ser(Tbu)-Oh

该化合物是一种受保护的精液衍生物,广泛用于peptide合成中.t-butyl(tBu)组保护氢氧基侧链,而boc(tert-butoxycolony)组保护氨基功能,确保在固态阶段或溶液阶段的peptide组装过程中有选择性地取消保护.该复合物具有很高的纯度和稳定性,适合要求合成应用.它的正方形保护组允许按顺序进行脱保,从而能够精确控制复杂的peptide序列.Bec-Ser(tBu)-OHA在生物活性活性聚物合成中特别有用,因为边链保护对于防止不想要的侧面反应至关重要.该产品通常用于药物研究和组合化学.

结构式图片

相似化合物

248921-66-6 128107-47-1 1676-75-1

欧盟法规

C&L通报REACH预注册

上下游产品

CAS号18942-50-2 N-叔丁氧羰基-O-叔丁基-L... | CAS号18822-58-7 O-叔丁基-L-丝氨酸

合成工艺路线路线简述

    N-叔丁氧羰基-O-叔丁基-L-丝氨酸二环己胺盐置于硫酸体系中,用 水,乙酸乙酯 用作溶剂,化学反应生成N-叔丁氧羰基-O-叔丁基-L-丝氨酸
    参考文献:Type 1,4-Naphtoquinone Compounds,Compositions Comprising Them And Use Of These Compounds As Anti-Cancer Agents
    标题:Type 1,4-Naphtoquinone Compounds,Compositions Comprising Them And Use Of These Compounds As Anti-Cancer Agents
    摘要:这项发明涉及以下给定的化合物(i)的公式或其药学上可接受的盐之一,作为药物;包含一个或多个具有公式(i)的化合物作为活性成分的药物组合物的公式(i),使用具有公式(i)的化合物制备旨在预防或治疗涉及异常细胞增殖的至少一种疾病的组合物,包含至少一种具有公式(i)的化合物的促凋亡组合物和/或抗增殖组合物,以及使用具有公式(i)的化合物作为促凋亡和/或抗增殖剂.

    海关参考信息

    专利信息


    专利号:US-9388212-B2
    优先权日:2013-02-21
    标 题:Solid phase peptide synthesis via side chain attachment
    发明人:BARLOS KLEOMENIS K
    权利人:CHEMICAL & BIOPHARMACEUTICAL LAB OF PATRAS S A
    摘要:The present application discloses peptides and peptaibols of high purity may be obtained by solid phase peptide synthesis using as the starting resin hydroxy amino acids, hydroxy amino acid amides, hydroxy amino alcohols or small peptides containing hydroxy amino acids attached to polymers through their side chain.

    专利号:US-2004110228-A1
    优先权日:2002-04-01
    标 题:Combinatorial organic synthesis of unique biologically active compounds
    发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
    摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

    专利号:US-11420997-B2
    优先权日:2018-04-13
    标题:Peptide synthesis method
    发明人:SUZUKI HIDEAKI; MUTO SUSUMU; FUJITA SHUJI; KUBO DAISUKE
    权利人:JITSUBO CO LTD
    摘要:The present invention has an object of shortening the process time and reducing use of a poor solvent for solidifying a carrier (Tag)-peptide component, by removing impurities without conducting solid-liquid separation (condensation, solid-liquid separation and drying operation) of a Tag-peptide component, in an Fmoc method using a Tag for liquid phase peptide synthesis. Provided is the peptide synthesis method that includes the following steps a-d: step a: a carrier-protected amino acid, carrier-protected peptide, or a carrier-protected amino acid amide, and an N-Fmoc-protected amino acid or an N-Fmoc-protected peptide are condensed in an organic solvent or a mixed solution of organic solvents, to obtain an N-Fmoc-carrier-protected peptide, step b: a water-soluble amine is added to the reaction solution after the condensation reaction, step c: the Fmoc group is deprotected from the protected amino group in the presence of a water-soluble amine, and step d: the reaction solution is neutralized by adding an acid, and further, by adding and washing with an acidic aqueous solution, then, by liquid-liquid separation an aqueous layer is removed to obtain an organic layer.

    专利号:US-8147799-B2
    优先权日:2007-01-11
    标题:Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
    发明人:MCBRIDE WILLIAM J; GOLDENBERG DAVID M
    权利人:MCBRIDE WILLIAM J; GOLDENBERG DAVID M; IMMUNOMEDICS INC
    摘要:The present application discloses compositions and methods of synthesis and use of F-18 labeled molecules of use, for example, in PET imaging techniques. In particular embodiments, the labeled molecules may be peptides or proteins, although other types of molecules including but not limited to aptamers, oligonucleotides and nucleic acids may be labeled and utilized for such imaging studies. In preferred embodiments, the F-18 label may be conjugated to a targeting molecule by formation of a metal complex and binding of the F-18-metal complex to a chelating moiety, such as DOTA, NOTA, DTPA, TETA or NETA. In other embodiments, the metal may first be conjugated to the chelating group and subsequently the F-18 bound to the metal. In other preferred embodiments, the F-18 labeled moiety may comprise a targetable conjugate that may be used in combination with a bispecific or multispecific antibody to target the F-18 to an antigen expressed on a cell or tissue associated with a disease, medical condition, or pathogen. Exemplary results show that F-18 labeled targetable conjugate peptides are stable in human serum at 37° C. for several hours, sufficient time to perform PET imaging analysis.

    专利号:US-8153100-B2
    优先权日:2007-01-11
    标题 :Methods and compositions for F-18 labeling of proteins, peptides and other molecules
    发明人:MCBRIDE WILLIAM J; D SOUZA CHRISTOPHER A; GOLDENBERG DAVID M
    权利人:MCBRIDE WILLIAM J; D SOUZA CHRISTOPHER A; GOLDENBERG DAVID M; IMMUNOMEDICS INC
    摘要:The present application discloses compositions and methods of synthesis and use of 18 F or 19 F labeled molecules of use in PET or MRI imaging. The labeled molecules may be peptides or proteins, although other types of molecules may be labeled. Preferably, the 18 F or 19 F is conjugated to a targeting molecule by formation of a metal complex and binding of the 18 F- or 19 F-metal complex to a chelating moiety. Alternatively, the metal may first be conjugated to the chelating group and subsequently the 18 F or 19 F bound to the metal. In other embodiments, the 18 F or 19 F labeled moiety may comprise a targetable construct used in combination with a bispecific antibody to target a disease-associated antigen. The 18 F or 19 F labeled targetable construct peptides are stable in serum at 37° C. for a sufficient time to perform PET or MRI imaging.

    专利号:US-8147800-B2
    优先权日:2007-01-11
    标 题 :Methods and compositions for F-18 labeling of proteins, peptides and other molecules
    发明人:MCBRIDE WILLIAM J; D SOUZA CHRISTOPHER A; GOLDENBERG DAVID M
    权利人:MCBRIDE WILLIAM J; D SOUZA CHRISTOPHER A; GOLDENBERG DAVID M; IMMUNOMEDICS INC
    摘要:The present application discloses compositions and methods of synthesis and use of F-18 labeled molecules of use, for example, in PET imaging techniques. The labeled molecules may be peptides or proteins, although other types of molecules may be labeled by the described methods. Preferably, the F-18 may be conjugated to a targeting molecule by formation of a metal complex and binding of the F-18-metal complex to a chelating moiety. Alternatively, the metal may first be conjugated to the chelating group and subsequently the F-18 bound to the metal. In other embodiments, the F-18 labeled moiety may comprise a targetable construct used in combination with a bispecific or multispecific antibody to target F-18 to a disease-associated antigen, such as a tumor-associated antigen. The F-18 labeled targetable construct peptides are stable in serum at 37° C. for a sufficient time to perform PET imaging analysis.
    四川同晟氨基酸有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: www.biots.cn
    企业联系电话:0838-2274206/13350585791👤
    📞四川同晟氨基酸有限公司 ⚠️参考联系方式
    联系人:舒先兰 赵女士
    电话:0838-2274206/13350585791
    手机:13908101207;13350585791
    传真:0838-2809448
    邮箱:sales@biots.cn
    通信地址: 四川省德阳市天元开发区永定河西路23号
    邮编: 618000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:四川省德阳市天元开发区永定河西路23号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海吉尔多肽有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.glbiochem.com
    电话: 86-21-61263309👤
    📞上海吉尔多肽有限公司 ⚠️参考联系方式

    销售电话:86-21-61263309
    邮箱:ymbetter@glbiochem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    成都安米诺泰医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.aminotp.com
    电话: 028-85755578 18140172005👤
    📞成都安米诺泰医药科技有限公司 ⚠️参考联系方式

    销售电话:028-85755578 18140172005
    邮箱:sales@aminotp.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海苏豪逸明制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.soho-yiming.com
    电话: 021-52692078👤
    📞上海苏豪逸明制药有限公司 ⚠️参考联系方式

    销售电话:021-52692078
    邮箱:info@soho-yiming.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Convergent Synthesis Of Calcium-Dependent Antibiotic Cda3A And Analogues With Improved Antibacterial Activity Via Late-Stage Serine Ligation
    作者:Delin Chen,Kathy Hiu Laam Po,Pilar Blasco,Sheng Chen,Xuechen Li |发布日期:2020.6.19
    摘要:A Convergent Synthesis Via The Late-Stage Serine Ligation Of Naturally Occurring Calcium-Dependent Antibiotic Cda3A And Its Analogues Has Been Developed, Which Allowed Us To Readily Synthesize The Analogues With The Variation On The Lipid Tail. Some Analogues Were Found To Show 100-500-Fold Higher Antimicrobial Activity Than The Natural Compound Cda3A Against Drug Resistant Bacteria. This Study Will

    合成参考文献


    参考文献:10.1007/s00289-012-0733-y
    摘要:Taniguchi I, Ootera Y, Chowdhury FA, Tomizaki K, Kai T, Kazama S. Polymeric membranes composed of polystyrenes tethering amino acids for preferential CO2 separation over H2. Polymer Bulletin. 2012 Mar 10;69(4):405–15. doi: 10.1007/s00289-012-0733-y.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知